Adam Lucas

521 total citations
14 papers, 381 citations indexed

About

Adam Lucas is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Adam Lucas has authored 14 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Adam Lucas's work include Neuroscience and Neuropharmacology Research (6 papers), Statistical Methods in Clinical Trials (4 papers) and Receptor Mechanisms and Signaling (3 papers). Adam Lucas is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Statistical Methods in Clinical Trials (4 papers) and Receptor Mechanisms and Signaling (3 papers). Adam Lucas collaborates with scholars based in United Kingdom, United States and Italy. Adam Lucas's co-authors include Robert J. Riley, Patrick Barton, Phil Jeffrey, Rod A. Porter, Kevin D. Read, Sharon C. Cheetham, Jeanette Watson, Jean Viggers, Alexander J. Stevens and Peter Kilford and has published in prestigious journals such as Epilepsia, British Journal of Clinical Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

Adam Lucas

14 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam Lucas United Kingdom	8	152	108	95	73	66	14	381
Stacey L. Becker United States	10	146 1.0×	112 1.0×	191 2.0×	70 1.0×	103 1.6×	10	465
Katelijne Anciaux Belgium	6	182 1.2×	66 0.6×	95 1.0×	40 0.5×	30 0.5×	8	459
Mithat Gunduz United States	12	192 1.3×	157 1.5×	86 0.9×	75 1.0×	25 0.4×	24	551
Etsuko Usuki United States	10	115 0.8×	102 0.9×	78 0.8×	27 0.4×	96 1.5×	14	429
Klaus Klinder Germany	13	143 0.9×	89 0.8×	50 0.5×	13 0.2×	53 0.8×	15	419
W F Pool United States	10	87 0.6×	52 0.5×	82 0.9×	44 0.6×	38 0.6×	16	328
Jegadeesan Vaigunda Ragavendran India	13	164 1.1×	93 0.9×	78 0.8×	30 0.4×	24 0.4×	19	562
U Svensson Sweden	9	257 1.7×	256 2.4×	63 0.7×	84 1.2×	22 0.3×	20	592
Wesley R. Anderson United States	16	153 1.0×	43 0.4×	100 1.1×	25 0.3×	75 1.1×	38	535
Łukasz Fijałkowski Poland	10	108 0.7×	53 0.5×	35 0.4×	31 0.4×	15 0.2×	20	377

Countries citing papers authored by Adam Lucas

Since Specialization

Citations

This map shows the geographic impact of Adam Lucas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Lucas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Lucas more than expected).

Fields of papers citing papers by Adam Lucas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Lucas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Lucas. The network helps show where Adam Lucas may publish in the future.

Co-authorship network of co-authors of Adam Lucas

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Lucas. A scholar is included among the top collaborators of Adam Lucas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Lucas. Adam Lucas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Lucas, Adam, Kayode Ogungbenro, Shuying Yang, Leon Aarons, & Chao Chen. (2021). Evaluation of area under the concentration curve adjusted by the terminal‐phase as a metric to reduce the impact of variability in bioequivalence testing. British Journal of Clinical Pharmacology. 88(2). 619–627. 1 indexed citations

Lucas, Adam, et al.. (2019). Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery. Expert Opinion on Drug Discovery. 14(12). 1313–1327. 95 indexed citations

Hunter, Robert P., et al.. (2012). How do you define equivalence of the API of biomass products?. Journal of Veterinary Pharmacology and Therapeutics. 35(s1). 99–101. 1 indexed citations

Cook, Jack, et al.. (2012). Estimating product bioequivalence for highly variable veterinary drugs. Journal of Veterinary Pharmacology and Therapeutics. 35(s1). 11–16. 6 indexed citations

Martinez, Marilyn N., Robert P. Hunter, Ronald E. Baynes, et al.. (2011). The 2010 AAVPT/EAVPT/ECVPT bioequivalence workshop. Journal of Veterinary Pharmacology and Therapeutics. 34(2). 105–107. 2 indexed citations

Nunamaker, Elizabeth A., et al.. (2011). Safety evaluation and treatment affect of LY2190416, a CB-1 antagonist/inverse agonist in growing beagle dogs. Journal of Veterinary Pharmacology and Therapeutics. 34(6). 577–582. 1 indexed citations

Forbes, Ian T., Steve P. Watson, Graeme I. Stevenson, et al.. (2010). The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists. Bioorganic & Medicinal Chemistry Letters. 20(18). 5434–5438. 16 indexed citations

Newhall, Karina, et al.. (2010). CB-1 antagonism with LY2190416 results in acute weight loss in obese adult dogs fed a high-fat diet. Journal of Veterinary Pharmacology and Therapeutics. 33(6). 615–618. 1 indexed citations

Kalinichev, Mikhail, Adam Lucas, Simon T. Bate, et al.. (2010). Potentiation of the anticonvulsant efficacy of sodium channel inhibitors by an NK1‐receptor antagonist in the rat. Epilepsia. 51(8). 1543–1551. 10 indexed citations

10.

Walker, Graham, Joanne Pardoe, Adam Lucas, et al.. (2010). NovelN-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M₁mAChR Agonists. ACS Medicinal Chemistry Letters. 1(6). 244–248. 40 indexed citations

11.

Walker, Graham, Adam Lucas, Ralph A. Rivero, et al.. (2010). 2′ Biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling. Bioorganic & Medicinal Chemistry Letters. 20(12). 3545–3549. 15 indexed citations

12.

Large, Charles H., Mikhail Kalinichev, Adam Lucas, et al.. (2009). The relationship between sodium channel inhibition and anticonvulsant activity in a model of generalised seizure in the rat. Epilepsy Research. 85(1). 96–106. 36 indexed citations

13.

Watson, Jeanette, Adam Lucas, Jean Viggers, et al.. (2009). Receptor Occupancy and Brain Free Fraction. Drug Metabolism and Disposition. 37(4). 753–760. 80 indexed citations

14.

Summerfield, Scott, Adam Lucas, Rod A. Porter, et al.. (2008). Toward an improved prediction of humanin vivobrain penetration. Xenobiotica. 38(12). 1518–1535. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact